Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, 98109, United States
NCT Number: NCT02650583
This pilot clinical trial studies the use of the Enhancing Connections Program in improving communication between patients with incurable cancer and their children. The Enhancing Connections Program is an educational program that may provide patients with new competencies to improve communication with their children and help them to cope with their parent's incurable cancer.
Looking for future studies?
Notify Me25 year–65 year
All sexes
Interventional
Not applicable
Seattle, Washington, 98109, United States
PRIMARY OBJECTIVES:
I. To test the feasibility of the study protocol in advanced cancer patients (recruitment/retention, dosage and fidelity of the intervention; program acceptability of program; and logistics).
II. To evaluate the short-term impact of the program on the diagnosed parents' and children's adjustment using a within group design (pre- and post-test design).
III. To compare outcomes from the Enhancing Connections Program with outcomes obtained from the completed Phase III trial (between group design).
OUTLINE:
Patients participate in Enhancing Connections Program comprising of anchoring patients to help their child, adding to listening skills, building on listening skills, being a detective of their child's coping, and celebrating success for 5 sessions. Patients also receive workbook which includes text from the sessions, handouts, and at-home assignments to be completed between sessions.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Receive Enhancing Connections Program
Other names: Education for Intervention, Intervention by Education, Intervention through Education, Intervention, Educational
Ancillary studies
Time frame: Baseline to up to 3 months
Baseline scores will be compared with post-intervention scores on the same measures. Analysis of covariance will be used to test for significant differences between pre- and post-test scores.
Time frame: Up to 3 months
Linear mixed modeling based on maximum likelihood estimation will be used to test the differences between the telephone-delivered and the in-person delivered program.
Time frame: Up to 3 months
Will be monitored for each intervention session using the performance checklists, the same checklists used to monitor dosage and fidelity in the Enhancing Connections (EC) trial. (Each session of the Program has its own unique Performance Checklist and each item is scored from 0-2. Performance Checklist items are specific to each session of the Program to be delivered by the patient educator. Higher scores denote higher performance by the patient educator and greater confidence that the Program was delivered as designed. The Performance Checklist is only used to monitor the performance of the
Time frame: Up to 3 months
Time frame: Up to 3 months
Three methods of recruitment will be monitored: self-referral, provider referral, and recruitment letter.
Time frame: Up to 3 months
Will be compared with outcomes obtained from the intervention group in the EC-RCT (historical comparison group).
Time frame: Up to 3 months
Assessed at baseline and post-intervention (up to 3 months).
Time frame: Up to 14 weeks
Assessed at baseline and post-intervention (up to 3 months).
Time frame: At Session 5, occurring within up to 3 months
Will be assessed from a debriefing interview in Session 5 that includes the parents' attributed gains of the program and their responses to the program's content, format, in-session, and at-home assignments.
Time frame: Baseline
Time frame: At Session 5, occurring within up to 3 months
University of Washington
Other
Enhancing Connections Program in Palliative Care: Taking Care of the Children
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03707574
Adnexal Diseases, Advanced Malignant Neoplasm
Fort Lauderdale, Florida, United States
View Trial DetailsNCT01582191
Advanced Malignant Neoplasm, Disease Attributes
Houston, Texas, United States
View Trial DetailsNCT05997342
Advanced Malignant Neoplasm
Changsha, Hunan, China
View Trial DetailsNCT06344351
Advanced Malignant Neoplasm
Hefei, Anhui, China
View Trial Details